Wanita dengan Sindrom Rupus : Lupus Eritematosus  Sistemik dan Artritis Reumatoid by Amiruddin, Asriani
Wanita dengan Sindrom Rupus : Lupus Eritematosus  
Sistemik dan Artritis Reumatoid, Asriani 
Alami Journal. Vol. 1 No. 1, Juli 2017 hal: 7-17 
 
7 
 
WANITA DENGAN SINDROM RUPUS :  
LUPUS ERITEMATOSUS SISTEMIK DAN ARTRITIS REUMATOID  
 
Asriani 
 
Program Studi Pendidikan Dokter Fakultas kedokteran dan Ilmu Kesehatan UIN Alauddin Makassar 
 
 
ABSTRACT 
 
Background : The coexistence of  two or  more connective tissue diseases in the same patient is a rare 
phenomenon, particularly the coexistence of Sytemic Lupus Erythematosus (SLE)  and Rheumatoid Arthrtitis 
(RA) (0,01 to 2%). Rhupus syndrome is a symmetric deforming polyarthritis of the small and large joints which 
is erosive on radiography and accompanied by clinical signs and symptoms of SLE and by the presence of 
specific autoantibodies with high specificity. 
Case : A young female, 29 years old with symmetric polyarthritis of both upper and lower limb joints for last 
six months  and was developed in two weeks. There was a history of hair loss for least 1 year. She also gave 
history of recurrent painful oral ulcers for last 6 months. Examination revealed alopecia, pallor, malar rash, and 
symmetric polyarthritis. The laboratory results were anemia, thrombocytopenia, positive anti-cyclic citrullinated 
peptide antibodies, positive rheumatoid factor, increased erythrocyte sedimentation rate, and the immunologic 
disorder characterized by positive anti-Sm. Plain radiographs of both hands showed  erosive polyarthritis. The 
treatment with methyl prednisolone, methotrexate, calcium, and folic acid. During treatment, she achieved 
clinical remission. 
Discussion : Symmetric  polyarthritis  at  the  young  age  are  affected  in 90% of the  patients  with  SLE  and 
RA. The beginning of which could not be defined, was coexistent with this overlap syndrome. Diagnosis of  RA 
based on  American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) and 
diagnosis of SLE based on ACR 1997 criteria. The therapy include low to moderate doses systemic 
corticosteroid and combination with 1-3 Disease-modifying anti-rheumatic drugs (DMARDs). 
 
Keywords : Rhupus Syndrome, Systemic Lupus Erythematosus, Rheumatoid Arthritis 
 
DAFTAR PUSTAKA 
1. Hochberg Mc. Updating the American College of Rheumatology revised criteria for the 
classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40: 1725 
2. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus 
erythematosus during a 10 year period, a comparison of early and late manifestation in a cohort 
of 1000 Patients. Medicine.2003;82: 299-308 
3. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid Arthritis Classification Criteria An 
American College of Rheumatology/European League Againts rheumatism Collaborative 
Initiative. Arthritis Rheum. 2010;62:2569-2581 
4. AlFadhli S, Nizam R. Rupus: A crosswalk between lupus and rheumatoid arthritis. OA 
Arthritis.2014:10;2(1):3 
5. Messuti L, Zoli A, Gremese E. Joint Involvement in SLE: the Controversy of Rhupus. 
International  Trends in Immunity.2014(2) 
Wanita dengan Sindrom Rupus : Lupus Eritematosus  
Sistemik dan Artritis Reumatoid, Asriani 
Alami Journal. Vol. 1 No. 1, Juli 2017 hal: 7-17 
 
8 
 
6. Popescu C, Zofota S, Bojinca V, et al. The Significance of Rheumatoid Factor and anti -Cyclic 
Citrullinated Peptide Antibodies in Systemic Lupus Erythematosus. Rom J  Intern Med. 2013:51; 
179-187 
7. Icen M, Nicola PJ, Maradit-Kremers H, et al. Systemic lupus erythematosus features in 
rheumatoid arthritis and their effect on overall mortality. J Rheumatol. 2009; 36:50-57  
8. Satoh M, Ajmani AK, Akizuki M. What is the definition for coexistent rheumatoid arthritis and 
systemic lupus erythematosus?.Lupus.1994; 3: 137-138 
9. Simon JA, granados J, Cabiedes J, et al. Clinical and immunogenetic characterization  of 
mexican patients with rupus. Lupus. 2002;11(5):287-92. 
10. Li J, Wu H, Huang X, et al. Clinical Analysis of 56 Patients With Rupus 
Syndrome:Manifestations and Comparisons With Systemic Lupus Erythematosus. Medicine. 
2014; 93(10):e49 
11. Kumar Y, Bhatia A, Minz RW. Anti nuclear antibodies and their detection methods in diagnosis 
of connective tissue diseases: a journey revisited. Diagnostic Pathology.2009;4:1 
12. Cohen MG, Webb J. Concurrence of rheumatoid arthritis and systemic lupus erythematosus: 
report of 11 cases. Ann Rheum Dis.1987;46:853-858. 
13. Sharma B. RUPUS: REPORT OF 3 CASES. J Indian Rheumatol Assoc. 2003;11:51-54 
14. Amezcua-Guerra LM, Springall R, Marquez-Velasco R, et al. Presence of antibodies against 
cyclic citrullinated peptides in patients with 'rupus': a cross-sectional study. Arthritis Research & 
Therapy.2006;8:144 
15. Tani C, D’Aniello D, Delle Sedie A, et al. Rupus syndrome: assessment of its prevalence and its 
clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun 
Rev. 2013;12:537-541 
16. Liu T, Li G, Mu R, Ye H, Li W, Li Z. Clinical and laboratory profiles of rupus syndrome in a 
Chinese population: a single-centre study of 51 patients. Lupus. 2014 Mar 7. [Epub ahead of 
print] . 
17. Chan MT, Owen P, Dunphy J, et al. Associations of erosive arthritis with anti -cyclic 
citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J 
Rheumatol. 2008; 35(1):77-83 
18. Hoffman IE, Peene I, Cebecauer L, et al.Presence of rheumatoid factor and antibodies to 
citrullinated peptides in systemic lupus erythematosus. Ann Rheum Dis. 2005;64:330-332 
19. Mediwake R, Isenberg DA, Schellekens GA, et al. Use of anti -citrullinated peptide and anti -
RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus 
and rheumatoid arthritis. Annals Rheum Dis.2001;60:67-68  
Wanita dengan Sindrom Rupus : Lupus Eritematosus  
Sistemik dan Artritis Reumatoid, Asriani 
Alami Journal. Vol. 1 No. 1, Juli 2017 hal: 7-17 
 
9 
 
20. Kakumanu P, Sobel ES, Narain S, et al. Citrulline Dependence of Anti -Cyclic Citrullinated 
Peptide Antibodies in Systemic Lupus Erythematosus as a Marker of Deforming/Erosive 
Arthritis. J Rheum.2009;36(12): 2682-2690  
21. Orozco G, Eyre S, Hinks A, et al. Study of the common genetic background for rheumatoid 
arthritis and systemic lupus erythematosus. Ann Rheum Dis.2011;70:463-468 
22. Orozco G, Barton A. Update on the genetic risk factors for rheumatoid arthritis. Expert Rev Clin 
Immunol. 2010; 6: 61-75  
23. Suarez-Gestal M, Calaza M, Dieguez-Gonzalez R, et al. Rheumatoid Arthritis Does Not Share 
Most of the Newly Identified Systemic Lupus Erythematosus Genetic Factors. Arthritis Rheum. 
2009; 60(9): 2558-2564 
